ARTICLE | Financial News
Spaltudaq raises $29 million
March 20, 2007 12:19 AM UTC
Antibody company Spaltudaq (Seattle, Wash.) raised $29 million in a series B round led by Arch Venture Partners and new investors Canaan Partners and Healthcare Ventures. Amgen Ventures; MPM Capital; ...